EWZ vs XBI
iShares MSCI Brazil ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.59% for EWZ.
- • EWZ pays a higher dividend yield (4.51%).
Side-by-side metrics
| Metric | EWZ | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.59% | 0.35% |
Dividend yield Trailing 12-month yield. | 4.51% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $9.62B | $10.92B |
YTD return | 3.62% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.92 | 1.01 |
P/E ratio | 10.36 | — |
Last price | $32.42 | $156.41 |
Inception | — | — |
Issuer | iShares | State Street |
EWZ top holdings
| VALE3.SA | Vale SA | 8.65% |
| PETR3.SA | Petroleo Brasileiro SA Petrobras | 8.47% |
| NU | Nu Holdings Ltd Ordinary Shares Class A | 8.47% |
| WEGE3.SA | Weg SA | 3.42% |
| AXIA3.SA | Axia Energia | 2.99% |
| EMBJ3.SA | Embraer SA | 2.99% |
| B3SA3.SA | B3 SA - Brasil Bolsa Balcao | 2.98% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About EWZ
EWZ (iShares MSCI Brazil ETF) is Brazilian large- and mid-cap equities. Managed by iShares, the fund carries $9.6B in assets under management, an expense ratio of 0.59%, a dividend yield of 4.51%. Its largest holding is Vale SA (VALE3.SA), which represents 8.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 1.5%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.